Misplaced Pages

Intracranial aneurysm
Other names	Cerebral aneurysm, brain aneurysm
Aneurysm of the basilar artery and the vertebral arteries
Specialty	Interventional neuroradiology, neurosurgery, neurology
Symptoms	None, severe headache, visual problems, nausea and vomiting, confusion
Usual onset	30–60 years old
Causes	Hypertension, infection, head trauma
Risk factors	old age, family history, smoking, alcoholism, cocaine use
Diagnostic method	Angiography, CT scan
Treatment	Endovascular coiling, surgical clipping, cerebral bypass surgery, pipeline embolization

An intracranial aneurysm, also known as a cerebral aneurysm, is a cerebrovascular disorder characterized by a localized dilation or ballooning of a blood vessel in the brain due to a weakness in the vessel wall. These aneurysms can occur in any part of the brain but are most commonly found in the arteries of the cerebral arterial circle. The risk of rupture varies with the size and location of the aneurysm, with those in the posterior circulation being more prone to rupture.

Cerebral aneurysms are classified by size into small, large, giant, and super-giant, and by shape into saccular (berry), fusiform, and microaneurysms. Saccular aneurysms are the most common type and can result from various risk factors, including genetic conditions, hypertension, smoking, and drug abuse.

Symptoms of an unruptured aneurysm are often minimal, but a ruptured aneurysm can cause severe headaches, nausea, vision impairment, and loss of consciousness, leading to a subarachnoid hemorrhage. Treatment options include surgical clipping and endovascular coiling, both aimed at preventing further bleeding.

Diagnosis typically involves imaging techniques such as CT or MR angiography and lumbar puncture to detect subarachnoid hemorrhage. Prognosis depends on factors like the size and location of the aneurysm and the patient’s age and health, with larger aneurysms having a higher risk of rupture and poorer outcomes.

Advances in medical imaging have led to increased detection of unruptured aneurysms, prompting ongoing research into their management and the development of predictive tools for rupture risk.

Classification

Cerebral aneurysms are classified both by size and shape. Small aneurysms have a diameter of less than 15 mm. Larger aneurysms include those classified as large (15 to 25 mm), giant (25 to 50 mm) (0.98 inches to 1.97 inches), and super-giant (over 50 mm).

Berry (saccular) aneurysms

Saccular aneurysms, also known as berry aneurysms, appear as a round outpouching and are the most common form of cerebral aneurysm. Causes include connective tissue disorders, polycystic kidney disease, arteriovenous malformations, untreated hypertension, tobacco smoking, cocaine and amphetamines, intravenous drug abuse (can cause infectious mycotic aneurysms), alcoholism, heavy caffeine intake, head trauma, and infection in the arterial wall from bacteremia (mycotic aneurysms).

Fusiform aneurysms

Fusiform dolichoectatic aneurysms represent a widening of a segment of an artery around the entire blood vessel, rather than just arising from a side of an artery's wall. They have an estimated annual risk of rupture between 1.6 and 1.9 percent.

Microaneurysms

Microaneurysms, also known as Charcot–Bouchard aneurysms, typically occur in small blood vessels (less than 300 micrometre diameter), most often the lenticulostriate vessels of the basal ganglia, and are associated with chronic hypertension. Charcot–Bouchard aneurysms are a common cause of intracranial hemorrhage.

Signs and symptoms

A small, unchanging aneurysm will produce few, if any, symptoms. Before a larger aneurysm ruptures, the individual may experience such symptoms as a sudden and unusually severe headache, nausea, vision impairment, vomiting, and loss of consciousness, or no symptoms at all.

Subarachnoid bleed

If an aneurysm ruptures, blood leaks into the space around the brain. This is called a subarachnoid hemorrhage. Onset is usually sudden without prodrome, classically presenting as a "thunderclap headache" worse than previous headaches. Symptoms of a subarachnoid hemorrhage differ depending on the site and size of the aneurysm. Symptoms of a ruptured aneurysm can include:

• a sudden severe headache that can last from several hours to days
• nausea and vomiting
• drowsiness, confusion and/or loss of consciousness
• visual abnormalities
• meningism
• dizziness

Almost all aneurysms rupture at their apex. This leads to hemorrhage in the subarachnoid space and sometimes in brain parenchyma. Minor leakage from aneurysm may precede rupture, causing warning headaches. About 60% of patients die immediately after rupture. Larger aneurysms have a greater tendency to rupture, though most ruptured aneurysms are less than 10 mm in diameter.

Microaneurysms

A ruptured microaneurysm may cause an intracerebral hemorrhage, presenting as a focal neurological deficit.

Rebleeding, hydrocephalus (the excessive accumulation of cerebrospinal fluid), vasospasm (spasm, or narrowing, of the blood vessels), or multiple aneurysms may also occur. The risk of rupture from a cerebral aneurysm varies according to the size of an aneurysm, with the risk rising as the aneurysm size increases.

Vasospasm

Vasospasm, referring to blood vessel constriction, can occur secondary to subarachnoid hemorrhage following a ruptured aneurysm. This is most likely to occur within 21 days and is seen radiologically within 60% of such patients. The vasospasm is thought to be secondary to the apoptosis of inflammatory cells such as macrophages and neutrophils that become trapped in the subarachnoid space. These cells initially invade the subarachnoid space from the circulation in order to phagocytose the hemorrhaged red blood cells. Following apoptosis, it is thought there is a massive degranulation of vasoconstrictors, including endothelins and free radicals, that cause the vasospasm.

Risk factors

Intracranial aneurysms may result from diseases acquired during life, or from genetic conditions. Hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Cocaine use has also been associated with the development of intracranial aneurysms.

Other acquired associations with intracranial aneurysms include head trauma and infections.

Genetic associations

Coarctation of the aorta is also a known risk factor, as is arteriovenous malformation. Genetic conditions associated with connective tissue disease may also be associated with the development of aneurysms. This includes:

• autosomal dominant polycystic kidney disease,
• neurofibromatosis type I,
• Marfan syndrome,
• multiple endocrine neoplasia type I,
• pseudoxanthoma elasticum,
• hereditary hemorrhagic telangiectasia and
• Ehlers-Danlos syndrome types II and IV.

Specific genes have also had reported association with the development of intracranial aneurysms, including perlecan, elastin, collagen type 1 A2, endothelial nitric oxide synthase, endothelin receptor A and cyclin dependent kinase inhibitor. Recently, several genetic loci have been identified as relevant to the development of intracranial aneurysms. These include 1p34–36, 2p14–15, 7q11, 11q25, and 19q13.1–13.3.

Pathophysiology

Aneurysm means an outpouching of a blood vessel wall that is filled with blood. Aneurysms occur at a point of weakness in the vessel wall. This can be because of acquired disease or hereditary factors. The repeated trauma of blood flow against the vessel wall presses against the point of weakness and causes the aneurysm to enlarge. As described by the law of Young-Laplace, the increasing area increases tension against the aneurysmal walls, leading to enlargement. In addition, a combination of computational fluid dynamics and morphological indices have been proposed as reliable predictors of cerebral aneurysm rupture.

Both high and low wall shear stress of flowing blood can cause aneurysm and rupture. However, the mechanism of action is still unknown. It is speculated that low shear stress causes growth and rupture of large aneurysms through inflammatory response while high shear stress causes growth and rupture of small aneurysm through mural response (response from the blood vessel wall). Other risk factors that contributes to the formation of aneurysm are: cigarette smoking, hypertension, female gender, family history of cerebral aneurysm, infection, and trauma. Damage to structural integrity of the arterial wall by shear stress causes an inflammatory response with the recruitment of T cells, macrophages, and mast cells. The inflammatory mediators are: interleukin 1 beta, interleukin 6, tumor necrosis factor alpha (TNF alpha), MMP1, MMP2, MMP9, prostaglandin E2, complement system, reactive oxygen species (ROS), and angiotensin II. However, smooth muscle cells from the tunica media layer of the artery moved into the tunica intima, where the function of the smooth muscle cells changed from contractile function into pro-inflammatory function. This causes the fibrosis of the arterial wall, with reduction of number of smooth muscle cells, abnormal collagen synthesis, resulting in a thinning of the arterial wall and the formation of aneurysm and rupture. No specific gene loci has been identified to be associated with cerebral aneurysms.

Generally, aneurysms larger than 7 mm in diameter should be treated because they are prone for rupture. Meanwhile, aneurysms less than 7 mm arise from the anterior and posterior communicating artery and are more easily ruptured when compared to aneurysms arising from other locations.

Saccular aneurysms

Saccular aneurysms are almost always the result of hereditary weaknesses in blood vessels and typically occur within the arteries of the circle of Willis, in order of frequency affecting the following arteries:

• Anterior communicating artery
• Posterior communicating artery
• Middle cerebral artery
• Internal carotid artery
• Tip of basilar artery

Saccular aneurysms tend to have a lack of tunica media and elastic lamina around their dilated locations (congenital), with a wall of sac made up of thickened hyalinized intima and adventitia. In addition, some parts of the brain vasculature are inherently weak—particularly areas along the circle of Willis, where small communicating vessels link the main cerebral vessels. These areas are particularly susceptible to saccular aneurysms. Approximately 25% of patients have multiple aneurysms, predominantly when there is a familial pattern.

Diagnosis

Once suspected, intracranial aneurysms can be diagnosed radiologically using magnetic resonance or CT angiography. But these methods have limited sensitivity for diagnosis of small aneurysms, and often cannot be used to specifically distinguish them from infundibular dilations without performing a formal angiogram. The determination of whether an aneurysm is ruptured is critical to diagnosis. Lumbar puncture (LP) is the gold standard technique for determining aneurysm rupture (subarachnoid hemorrhage). Once an LP is performed, the CSF is evaluated for RBC count, and presence or absence of xanthochromia.

Treatment

Emergency treatment for individuals with a ruptured cerebral aneurysm generally includes restoring deteriorating respiration and reducing intracranial pressure. Currently there are two treatment options for securing intracranial aneurysms: surgical clipping or endovascular coiling. If possible, either surgical clipping or endovascular coiling is typically performed within the first 24 hours after bleeding to occlude the ruptured aneurysm and reduce the risk of recurrent hemorrhage.

While a large meta-analysis found the outcomes and risks of surgical clipping and endovascular coiling to be statistically similar, no consensus has been reached. In particular, the large randomised control trial International Subarachnoid Aneurysm Trial appears to indicate a higher rate of recurrence when intracerebral aneurysms are treated using endovascular coiling. Analysis of data from this trial has indicated a 7% lower eight-year mortality rate with coiling, a high rate of aneurysm recurrence in aneurysms treated with coiling—from 28.6 to 33.6% within a year, a 6.9 times greater rate of late retreatment for coiled aneurysms, and a rate of rebleeding 8 times higher than surgically clipped aneurysms.

Surgical clipping

Aneurysms can be treated by clipping the base of the aneurysm with a specially-designed clip. Whilst this is typically carried out by craniotomy, a new endoscopic endonasal approach is being trialled. Surgical clipping was introduced by Walter Dandy of the Johns Hopkins Hospital in 1937. After clipping, a catheter angiogram or CTA can be performed to confirm complete clipping.

Endovascular coiling

Endovascular coiling refers to the insertion of platinum coils into the aneurysm. A catheter is inserted into a blood vessel, typically the femoral artery, and passed through blood vessels into the cerebral circulation and the aneurysm. Coils are pushed into the aneurysm, or released into the blood stream ahead of the aneurysm. Upon depositing within the aneurysm, the coils expand and initiate a thrombotic reaction within the aneurysm. If successful, this prevents further bleeding from the aneurysm. In the case of broad-based aneurysms, a stent may be passed first into the parent artery to serve as a scaffold for the coils.

Cerebral bypass surgery

Cerebral bypass surgery was developed in the 1960s in Switzerland by Gazi Yaşargil. When a patient has an aneurysm involving a blood vessel or a tumor at the base of the skull wrapping around a blood vessel, surgeons eliminate the problem vessel by replacing it with an artery from another part of the body.

Prognosis

Outcomes depend on the size of the aneurysm. Small aneurysms (less than 7 mm) have a low risk of rupture and increase in size slowly. The risk of rupture is less than one percent for aneurysms of this size.

The prognosis for a ruptured cerebral aneurysm depends on the extent and location of the aneurysm, the person's age, general health, and neurological condition. Some individuals with a ruptured cerebral aneurysm die from the initial bleeding. Other individuals with cerebral aneurysm recover with little or no neurological deficit. The most significant factors in determining outcome are the Hunt and Hess grade, and age. Generally patients with Hunt and Hess grade I and II hemorrhage on admission to the emergency room and patients who are younger within the typical age range of vulnerability can anticipate a good outcome, without death or permanent disability. Older patients and those with poorer Hunt and Hess grades on admission have a poor prognosis. Generally, about two-thirds of patients have a poor outcome, death, or permanent disability.

Increased availability and greater access to medical imaging has caused a rising number of asymptomatic, unruptured cerebral aneurysms to be discovered incidentally during medical imaging investigations. Unruptured aneurysms may be managed by endovascular clipping or stenting. For those subjects that underwent follow-up for the unruptured aneurysm, computed tomography angiography (CTA) or magnetic resonance angiography (MRA) of the brain can be done yearly. Recently, an increasing number of aneurysm features have been evaluated in their ability to predict aneurysm rupture status, including aneurysm height, aspect ratio, height-to-width ratio, inflow angle, deviations from ideal spherical or elliptical forms, and radiomics morphological features.

Epidemiology

The prevalence of intracranial aneurysm is about 1–5% (10 million to 12 million persons in the United States) and the incidence is 1 per 10,000 persons per year in the United States (approximately 27,000), with 30- to 60-year-olds being the age group most affected. Intracranial aneurysms occur more in women, by a ratio of 3 to 2, and are rarely seen in pediatric populations.

See also

• Interventional neuroradiology
• Intradural pseudoaneurysm

References

1. ^ "Brain aneurysm - Symptoms and causes". Mayo Clinic.
2. "What is an Aneurysm?".
3. ^ "What You Should Know About Cerebral Aneurysms". www.hopkinsmedicine.org. 8 August 2021.
4. Bhidayasiri R, Waters MF, Giza CC (2005). Neurological differential diagnosis : a prioritized approach (3. Dr. ed.). Oxford: Blackwell Publishing. p. 133. ISBN 978-1-4051-2039-5.
5. Koutsothanasis G.A.; Sampath R., Berry Aneurysm (update: October 2, 2020). Link https://www.ncbi.nlm.nih.gov/books/NBK557480/
6. Xu DS, Levitt MR, Kalani MY, Rangel-Castilla L, Mulholland CB, Abecassis IJ, Morton RP, Nerva JD, Siddiqui AH, Levy EI, Spetzler RF (2017-04-07). "Dolichoectatic aneurysms of the vertebrobasilar system: clinical and radiographic factors that predict poor outcomes". Journal of Neurosurgery. 128 (2): 560–66. doi:10.3171/2016.10.JNS161041. ISSN 1933-0693. PMID 28387624.
7. Fusiform and dolichoectatic aneurysms By James R Brorson MD (Dr. Brorson of the University of Chicago received consultation fees from CVS-Caremark, National Peer Review Corporation, and Medico-legal Consulting.) Originally released October 28, 1997; last updated January 29, 2017; expires January 29, 2020 https://tcapp.org/wp-content/uploads/2017/09/Fusiform-and-Dolichoectatic-Aneurysms.pdf Archived 2021-05-06 at the Wayback Machine
8. Kumar, Abbas, Fausto, eds. (2005). Robbins and Cotran Pathologic Basis of Disease (7th ed.). China: Elsevier. ISBN 978-0-7216-0187-8.
9. Gupta K, M Das J (2021), Charcot Bouchard Aneurysm, Treasure Island (FL): StatPearls Publishing, PMID 31971704, retrieved 2021-05-06
10. ^ Brisman JL, Song, JK, Newell, DW (Aug 31, 2006). "Cerebral aneurysms". The New England Journal of Medicine. 355 (9): 928–39. doi:10.1056/nejmra052760. PMID 16943405.
11. ^ Goljan, Edward F. (2006). Rapid Review Pathology (2nd ed.). St. Louis: Mosby. p. 158. ISBN 978-0-323-04414-1.
12. ^ Alway D, Cole JW, eds. (2009). Stroke Essentials for Primary Care: A Practical Guide. New York: Humana Press. pp. 86–88, 153. ISBN 978-1-934115-01-5.
13. Publishing HH (18 December 2018). "Subarachnoid Hemorrhage". Harvard Health. Retrieved 2021-05-06.
14. ^ DiMaio VJ, DiMaio D (2001). Forensic pathology (2nd ed.). Boca Raton, FL: CRC Press. p. 61. ISBN 978-0-8493-0072-1.
15. Korja Miikka, Lehto Hanna, Juvela Seppo (2014-07-01). "Lifelong Rupture Risk of Intracranial Aneurysms Depends on Risk Factors". Stroke. 45 (7): 1958–63. doi:10.1161/STROKEAHA.114.005318. PMID 24851875.
16. Gallia GL, Tamargo, Rafael J. (1 October 2006). "Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage". Neurological Research. 28 (7): 750–58. doi:10.1179/016164106X152025. PMID 17164038. S2CID 27713975.
17. ^ Brown Walter L. Kemp, Dennis K. Burns, Travis G. (2008). Pathology the big picture. New York: McGraw-Hill Medical. p. 148. ISBN 978-0-07-159379-3.{{cite book}}: CS1 maint: multiple names: authors list (link)
18. Caranci F, Briganti, F., Cirillo, L., Leonardi, M., Muto, M. (2012). "Epidemiology and genetics of intracranial aneurysms". European Journal of Radiology. 82 (10): 1598–605. doi:10.1016/j.ejrad.2012.12.026. PMID 23399038.
19. van der Voet M, Olson, J, Kuivaniemi, H, Dudek, D, Skunca, M, Ronkainen, A, Niemelä, M, Jääskeläinen, J, Hernesniemi, J, Helin, K (1 March 2004). "Intracranial Aneurysms in Finnish Families: Confirmation of Linkage and Refinement of the Interval to Chromosome 19q13.3". The American Journal of Human Genetics. 74 (3): 564–71. doi:10.1086/382285. PMC 1182270. PMID 14872410.
20. ^ Haberland C (2007). Clinical neuropathology : text and color atlas (Online-Ausg. ed.). New York: Demos. p. 70. ISBN 978-1-888799-97-2.
21. Humphrey JD, Kyriacou SK (June 1996). "The use of Laplace's equation in aneurysm mechanics". Neurological Research. 18 (3): 204–08. doi:10.1080/01616412.1996.11740404. ISSN 0161-6412. PMID 8837052.
22. "Laplace's Law and Aneurysms". sciencedemonstrations.fas.harvard.edu. Retrieved 2021-05-06.
23. Hademenos GJ (2008-01-11). "The Physics of Cerebral Aneurysms". Physics Today. 48 (2): 24. doi:10.1063/1.881442. ISSN 0031-9228.
24. Amigo N, Valencia A, Wu W, Patnaik S, Finol E (2021-03-08). "Cerebral aneurysm rupture status classification using statistical and machine learning methods". Proceedings of the Institution of Mechanical Engineers, Part H. 235 (6): 655–662. doi:10.1177/09544119211000477. ISSN 2041-3033. PMID 33685288. S2CID 232161029.
25. ^ Chalouhi N, Loh BL, Hasan D (25 November 2013). "Review of Cerebral Aneurysm Formation, Growth, and Rupture". Stroke. 44 (12): 3613–22. doi:10.1161/STROKEAHA.113.002390. PMID 24130141.
26. "berry aneurysm" at Dorland's Medical Dictionary
27. Howlett D, Ayers B (2004). The hands-on guide to imaging. Oxford: Blackwell. p. 204. ISBN 978-1-4051-1551-3.
28. ^ White PM, Teasdale EM, Wardlaw JM, Easton V (2001-06-01). "Intracranial Aneurysms: CT Angiography and MR Angiography for Detection – Prospective Blinded Comparison in a Large Patient Cohort". Radiology. 219 (3): 739–49. doi:10.1148/radiology.219.3.r01ma16739. ISSN 0033-8419. PMID 11376263.
29. Greenberg M (2010). Handbook of neurosurgery. Greenberg Graphics. ISBN 978-1-60406-326-4. OCLC 892183792.
30. Mark DG, Kene MV, Offerman SR, Vinson DR, Ballard DW (2015). "Validation of cerebrospinal fluid findings in aneurysmal subarachnoid hemorrhage". The American Journal of Emergency Medicine. 33 (9): 1249–52. doi:10.1016/j.ajem.2015.05.012. PMID 26022754.
31. Park J, Woo H, Kang DH, Kim YS, Kim MY, Shin IH, Kwak SG (2015-02-01). "Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes". Journal of Neurosurgery. 122 (2): 383–91. doi:10.3171/2014.9.JNS131784. ISSN 1933-0693. PMID 25403841.
32. Raja PV, Huang, J, Germanwala, AV, Gailloud, P, Murphy, KP, Tamargo, RJ (June 2008). "Microsurgical clipping and endovascular coiling of intracranial aneurysms: a critical review of the literature". Neurosurgery. 62 (6): 1187–202, discussion 1202–03. doi:10.1227/01.neu.0000333291.67362.0b. PMID 18824986.
33. Mitchell P, Kerr R, Mendelow AD, Molyneux A. "Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in ISAT?" Journal of Neurosurgery 108: 437–42, March 2008
34. Piotin M, Spelle, L, Mounayer, C, Salles-Rezende, MT, Giansante-Abud, D, Vanzin-Santos, R, Moret, J (May 2007). "Intracranial aneurysms: treatment with bare platinum coils – aneurysm packing, complex coils, and angiographic recurrence". Radiology. 243 (2): 500–08. doi:10.1148/radiol.2431060006. PMID 17293572.
35. Raymond J, Guilbert, F, Weill, A, Georganos, SA, Juravsky, L, Lambert, A, Lamoureux, J, Chagnon, M, Roy, D (June 2003). "Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils". Stroke. 34 (6): 1398–1403. doi:10.1161/01.STR.0000073841.88563.E9. PMID 12775880.
36. Campi A, Ramzi N, Molyneux AJ, Summers PE, Kerr RS, Sneade M, Yarnold JA, Rischmiller J, Byrne JV (May 2007). "Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT)". Stroke. 38 (5): 1538–44. doi:10.1161/STROKEAHA.106.466987. PMID 17395870.
37. Mitchell P, Kerr R, Mendelow AD, Molyneux A (March 2008). "Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the International Subarachnoid Aneurysm Trial?". J. Neurosurg. 108 (3): 437–42. doi:10.3171/JNS/2008/108/3/0437. PMID 18312088. S2CID 24304414.
38. "Germanwala Presents First Aneurysm Patient Treated Through Nose". UNC. June 25, 2009.
39. Sasidharan GM, Sastri SB, Pandey P (1 January 2015). "Aneurysm clips: What every resident should know". Neurology India. 63 (1) – via www.neurologyindia.com.
40. Bharatha A, Yeung R, Durant D, Fox AJ, Aviv RI, Howard P, Thompson AL, Bartlett ES, Symons SP. "Comparison of computed tomography angiography with digital subtraction angiography in the assessment of clipped intracranial aneurysms". Journal of Computer Assisted Tomography. 2010 May–June; 34(3): 440–45.
41. Brilstra EH, Rinkel GJ, van der Graaf Y, van Rooij WJ, Algra A (February 1999). "Treatment of intracranial aneurysms by embolization with coils: a systematic review". Stroke. 30 (2): 470–76. doi:10.1161/01.STR.30.2.470. PMID 9933290.
42. Oushy S, Rinaldo L, Brinjikji W, Cloft H, Lanzino G (June 2020). "Recent advances in stent-assisted coiling of cerebral aneurysms". Expert Review of Medical Devices. 17 (6): 519–32. doi:10.1080/17434440.2020.1778463. ISSN 1745-2422. PMID 32500761. S2CID 219328499.
43. Spetzler R, Chater N (1 November 1976). "Microvascular bypass surgery". Journal of Neurosurgery. 45 (5): 508–13. doi:10.3171/jns.1976.45.5.0508. PMID 972334.
44. ^ Malhotra A, Wu X, Forman HP, Grossetta Nardini HK, Matouk CC, Gandhi D, Moore C, Sanelli P (July 2017). "Growth and Rupture Risk of Small Unruptured Intracranial Aneurysms: A Systematic Review". Ann. Intern. Med. 167 (1): 26–33. doi:10.7326/M17-0246. PMID 28586893.
45. Hop JW, Rinkel, G. J.E., Algra, A., van Gijn, J. (1 March 1997). "Case-Fatality Rates and Functional Outcome After Subarachnoid Hemorrhage : A Systematic Review". Stroke. 28 (3): 660–64. doi:10.1161/01.STR.28.3.660. PMID 9056628.
46. Ljunggren B, Sonesson, B, Säveland, H, Brandt, L (May 1985). "Cognitive impairment and adjustment in patients without neurological deficits after aneurysmal SAH and early operation". Journal of Neurosurgery. 62 (5): 673–79. doi:10.3171/jns.1985.62.5.0673. PMID 3989590. S2CID 26649695.
47. Vernooij MW, Ikram, MA, Tanghe, HL (2007). "Incidental findings on brain MRI in the general population.Incidental findings on brain MRI in the general population". N Engl J Med. 357 (5): 1821–28. doi:10.1056/NEJMoa070972. PMID 17978290.
48. Thompson BG, Brown RD, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES, Duckwiler GR, Harris CC, Howard VJ, Johnston SC, Meyers PM, Molyneux A, Ogilvy CS, Ringer AJ, Torner J (August 2015). "Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. 46 (8): 2368–2400. doi:10.1161/STR.0000000000000070. ISSN 0039-2499. PMID 26089327.
49. Ludwig CG, Lauric, A, Malek, JA, Mulligan, R, Malek, AM (2020). "Performance of Radiomics derived morphological features for prediction of aneurysm rupture status". Journal of NeuroInterventional Surgery. 13 (8). doi:10.1136/neurintsurg-2020-016808. PMID 33158993. S2CID 226274492.

External links

• National Institute of Neurological Disorders and Stroke

• Cerebrovascular diseases
• Neurosurgery